Clinical Trial Simulations From a Model-Based Meta-Analysis of Studies in Patients With Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy.

Autor: Zierhut, ML¹, Chen, Y², Pithavala, YK², Nickens, DJ¹, Valota, O³, Amantea, MA¹

Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. May2016, Vol. 5 Issue 5, p274-282. 9p.

(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.

Autor: Zierhut ML, Ozturk-Isik E, Chen AP, Park I, Vigneron DB, Nelson SJ, Zierhut, Matthew L, Ozturk-Isik, Esin, Chen, Albert P, Park, Ilwoo, Vigneron, Daniel B, Nelson, Sarah J

Publikováno v: Journal of Magnetic Resonance Imaging; Sep2009, Vol. 30 Issue 3, p473-480, 8p

Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies.

Autor: Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.; Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA., Keenan AJ; Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA. AKeenan1@its.jnj.com., Le HH; Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA., Ait-Tihyaty M; Janssen Pharmaceuticals, Titusville, NJ, USA., Gandhi K; Janssen Pharmaceuticals, Titusville, NJ, USA., Zierhut ML; Certara USA, Inc., Radnor, PA, USA., Salvo-Halloran EM; EVERSANA, Value & Evidence Services, Burlington, ON, Canada., Ramirez AO; EVERSANA, Value & Evidence Services, Burlington, ON, Canada., Vuong V; EVERSANA, Value & Evidence Services, Burlington, ON, Canada., Singh S; EVERSANA, Value & Evidence Services, Burlington, ON, Canada., Hutton B; Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Publikováno v: BMC neurology [BMC Neurol] 2024 Oct 08; Vol. 24 (1), pp. 378. Date of Electronic Publication: 2024 Oct 08.

Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab.

Autor: Williams JH; Pfizer Inc., San Diego, California, USA., Hutmacher MM; Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan, USA., Zierhut ML; Pfizer Inc., San Diego, California, USA., Becker JC; Pfizer Inc., New York, New York, USA., Gumbiner B; Pfizer Inc., San Diego, California, USA., Spencer-Green G; Pfizer Inc., Cambridge, Massachusetts, USA., Melia LA; Pfizer Inc., San Diego, California, USA., Liao KH; Pfizer Inc., San Diego, California, USA., Suster M; Pfizer Inc., San Diego, California, USA., Yin D; Pfizer Inc., San Diego, California, USA., Li R; Pfizer Inc., Cambridge, Massachusetts, USA., Meng X; Pfizer Inc., San Diego, California, USA.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Dec; Vol. 82 (6), pp. 1568-1579. Date of Electronic Publication: 2016 Sep 22.

Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer.

Autor: Lupo JM; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA 94158, USA. janinel@radiology.ucsf.edu, Chen AP, Zierhut ML, Bok RA, Cunningham CH, Kurhanewicz J, Vigneron DB, Nelson SJ

Publikováno v: Magnetic resonance imaging [Magn Reson Imaging] 2010 Feb; Vol. 28 (2), pp. 153-62. Date of Electronic Publication: 2009 Aug 19.